Skip to main content
Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2024. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed March 21, 2024.
  2. Albuterol sulfate inhalation solution 0.083% package insert. Nephron Pharmaceuticals Corp., January 2021.
  3. Albuterol sulfate inhalation solution 0.5% package insert. Nephron Pharmaceuticals Corporation, January 2021.
  4. Albuterol sulfate solution 0.63 mg/3 ml, 1.25 mg/3 ml package insert. Ritedose Pharmaceuticals, LLC., December 2023.
  5. Levalbuterol inhalation solution (Xopenex) package insert. Akorn., December 2018.
  6. Arformoterol inhalation solution (Brovana) package insert. Lupin Pharmaceuticals Inc., October 2023.
  7. Formoterol inhalation solution (Perforomist) package insert. Mylan Specialty, May 2019.
  8. Revefenacin inhalation solution (Yupelri) package insert. Mylan Specialty LP, May 2022.
  9. Ipratropium bromide inhalation solution 0.02% package insert. American Health Packaging, October, 2022.
  10. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. Expert Panel 3: guidelines for the diagnosis and management of asthma. Full report 2007. NIH Publication No. 08-4051. Available at: https://www.nhlbi.nih.gov/sites/default/files/media/docs/asthgdln_1.pdf.  Accessed March 22, 2024.
  11. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2023 update. Available at: https://ginasthma.org/wp-content/uploads/2023/07/GINA-2023-Full-report-23_07_06-WMS.pdf . Accessed March 22, 2024.
  12. Ipratropium bromide and albuterol sulfate inhalation solution package insert. Aurobindo Pharma Limited, October 2023.
  13. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Accessed March 22, 2024.
  14. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. 2023 Report. Available at:  https://goldcopd.org/2023-gold-report-2/. Accessed March 22, 2024.